- Home
- BNTC vs EVMN Comparison
BNTC vs EVMN Comparison
Compare BNTC & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTC | EVMN |
|---|---|---|
| Founded | 1995 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.2M | 405.2M |
| IPO Year | 2020 | 2025 |
Fundamental Metrics
Financial Performance| Metric | BNTC | EVMN |
|---|---|---|
| Price | $13.68 | $13.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | $27.67 | ★ $43.88 |
| AVG Volume (30 Days) | 162.0K | ★ 465.8K |
| Earning Date | 05-14-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 80.94 | 75.23 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $13,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 85.71 |
| 52 Week Low | $9.85 | $10.47 |
| 52 Week High | $16.76 | $33.20 |
Technical Indicators
Market Signals| Indicator | BNTC | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 60.62 | 50.34 |
| Support Level | $11.28 | $13.89 |
| Resistance Level | $13.79 | $21.21 |
| Average True Range (ATR) | 0.83 | 0.77 |
| MACD | 0.07 | 0.25 |
| Stochastic Oscillator | 89.02 | 65.79 |
Price Performance
Historical ComparisonAbout BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.